Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth...

Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust
Growth In Emphysema Treatment Market, According to Millennium Research Group

WALTHAM, Mass., June 16 /PRNewswire/ -- According to Millennium Research Group
(MRG), the global authority on medical technology market intelligence, the
rise in the US prevalence of emphysema is prompting device firms to develop
endoscopic devices used to diagnose or treat the condition. Currently, only
two surgical treatment options for emphysema are available: lung volume
reduction or lung transplant, both of which involve substantial risks for the
patient. MRG's US Markets for ENT and Bronchoscopy Devices 2009 finds that the
minimally invasive devices in development, anticipated to launch in the US
market over the next five years, will offer more options for these patients.

Devices such as Spiration's IBV Valve System, Broncus Technologies' Exhale
stent, Aeris Therapeutics' Polymeric Lung Volume Reduction System, and
PneumRX's steerable biopsy needles have undergone at least phase I clinical
testing in the US. Some of these technologies are expected to receive FDA
approval before 2013, bringing minimally invasive technology to the emphysema
patient population.

"The release of these minimally invasive devices will create new market
opportunities and will positively affect the existing market for flexible
bronchoscopes, which will act as conduits for many of the new devices used,"
says Tiffanie Demone, Senior Analyst at MRG. "By 2013, the white light video
flexible bronchoscope market will experience growth of more than 13%."

MRG's US Markets for ENT and Bronchoscopy Devices 2009 report provides an
affordable, off-the-shelf solution to tracking important ENT and bronchoscopy
market segments and competitor dynamics. This report allows clients to assess
the effect of the economic downturn, plan for the future, tap into deep
segmentation, and leverage downturn-adjusted 5-year forecasts, up-to-date
market shares, and in-depth qualitative insights.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company
(www.DecisionResourcesInc.com), is the global authority on medical technology
market intelligence and the leading provider of strategic information to the
health care sector. The company provides specialized industry expertise
through multiclient market research, ongoing Marketrack(TM) projects, customer
loyalty tracking, facility-level procedure forecasting, and customized
solutions.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers
best-in-class, high-value information, and insights on important sectors of
the health care industry. Clients rely on this analysis and data to make
informed decisions. Please visit Decision Resources, Inc. at
www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net

Elizabeth Marshall
Decision Resources Inc.
781-296-2563
emarshall@dresources.com

SOURCE Millennium Research Group

Amy Krohn of Millennium Research Group, +1-416-364-7776 ext. 101,
akrohn@mrg.net, or Elizabeth Marshall of Decision Resources Inc.,
+1-781-296-2563, emarshall@dresources.com